Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A. (N/A)
Lundbeck LLC (N/A)
Received: 3 November 2020
Accepted: 19 July 2021
First Online: 6 August 2021
: Not applicable (non-interventional retrospective study using existing data from Magellan’s medical/pharmacy claims database).
: Not applicable.
: AK and MP are employees of Magellan Method, a Division of Magellan Rx Management. DFL, TE, and LC are employees of Takeda Pharmaceuticals U.S.A., Inc. MT is an employee of Lundbeck LLC. The sponsors were responsible for study design; collection, analysis, and interpretation of data; and the decision to submit the report for publication.